Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Références<br />
237. Lambert J, Halfon P, Penaranda G, Bedossa P, Cacoub P, Carrat F. How to measure the diagnostic accuracy<br />
of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem. 2008<br />
Aug;54(8):1372-8.<br />
238. Sebastiani G, Vario A, Guido M, Noventa F, P<strong>le</strong>bani M, Pistis R, et al. Stepwise combination algorithms of<br />
non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol. 2006;44:686-93.<br />
239. Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, et al. Comparison of test performance<br />
profi<strong>le</strong> for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol. 2007 Mar;46(3):395-402.<br />
240. Ca<strong>le</strong>s P, Oberti F, Michalak S, Hubert-Fouchard I, Rousse<strong>le</strong>t MC, Konate A, et al. A novel panel of blood<br />
markers to assess the degree of liver fibrosis. Hepatology. 2005 Dec;42(6):1373-81.<br />
241. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated<br />
predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51:1867-73.<br />
242. Wai CT, Greenson JK, Fontana RJ, Kalbf<strong>le</strong>isch JD, Marrero JA, Conjeevaram HS, et al. A simp<strong>le</strong><br />
noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.<br />
Hepatology. 2003;38:518-26.<br />
243. Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, et al. Comparison and validation of simp<strong>le</strong><br />
noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376-82.<br />
244. Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, et al. Validation and comparison of<br />
indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach<br />
classification without liver biopsies. J Viral Hepat. 2006;13:659-70.<br />
245. Val<strong>le</strong>t-Pichard A, Mal<strong>le</strong>t V, Pol S. FIB-4: a simp<strong>le</strong>, inexpensive and accurate marker of fibrosis in HCVinfected<br />
patients. Hepatology. 2006 Sep;44(3):769; author reply -70.<br />
246. Ad<strong>le</strong>r M, Gulbis B, Moreno C, Evrard S, Verset G, Golstein P, et al. The predictive value of FIB-4 versus<br />
FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and<br />
nonhepatitis C liver diseases. Hepatology. 2008 Feb;47(2):762-3; author reply 3.<br />
247. de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis<br />
and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic<br />
Syndr. 2006;41:175-9.<br />
248. Al-Mohri H, Cooper C, Murphy T, K<strong>le</strong>in MB. Validation of a simp<strong>le</strong> model for predicting liver fibrosis in<br />
HIV/hepatitis C virus-coinfected patients. HIV Med. 2005 Nov;6(6):375-8.<br />
249. Salmon-Céron D, Gouëzel P, Delarocque-Astagneau E, Piroth L, Dellamonica P, Marcellin P, et al. Coinfection<br />
VIH-VHC à l'hôpital. Enquête nationa<strong>le</strong> juin 2001. Médecine et Maladies Infectieuses. 2003;33:78-<br />
83.<br />
250. Cacoub P, Halfon P, Rosenthal E, Pialoux G, Benhamou Y, Perronne C, et al. Treatment of hepatitis C virus<br />
in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between<br />
2004 and 2006. J Hepatol. 2008 Jan;48(1):35-42.<br />
251. INVS. L’infection à VIH/Sida en France et en Europe. BEH. 2007;46-47.<br />
252. Merchante N, Rivero A, de Los Santos-Gil I, Merino D, Marquez M, Lopez-Ruz MA, et al. Insulin resistance<br />
is associated with liver stiffness in HIV/HCV-coinfected patients. Gut. 2009 Jul 21.<br />
253. Ryan P, Berenguer J, Michelaud D, Miral<strong>le</strong>s P, Bellon JM, Alvarez E, et al. Insulin resistance is associated<br />
with advanced liver fibrosis and high body mass index in HIV/HCV-coinfected patients. J Acquir Immune<br />
Defic Syndr. 2009 Jan 1;50(1):109-10.<br />
254. Okuda M, Li K, Beard MR, Showalter LA, Schol<strong>le</strong> F, Lemon SM, et al. Mitochondrial injury, oxidative<br />
stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002<br />
Feb;122(2):366-75.<br />
255. Neuman MG, Benhamou JP, Malkiewicz IM, Ibrahim A, Valla DC, Martinot-Peignoux M, et al. Kinetics of<br />
serum cytokines ref<strong>le</strong>ct changes in the severity of chronic hepatitis C presenting minimal fibrosis. J Viral<br />
Hepat. 2002 Mar;9(2):134-40.<br />
256. Ristig M, Drechs<strong>le</strong>r H, Powderly WG. Hepatic steatosis and HIV infection. AIDS Patient Care STDS. 2005<br />
Jun;19(6):356-65.<br />
257. Guaraldi G, Squillace N, Stentarelli C, Orlando G, D'Amico R, Ligabue G, et al. Nonalcoholic fatty liver<br />
disease in HIV-infected patients referred to a metabolic clinic: preva<strong>le</strong>nce, characteristics, and predictors. Clin<br />
Infect Dis. 2008 Jul 15;47(2):250-7.<br />
258. Brau N, Salvatore M, Rios-Bedoya CF, Fernandez-Carbia A, Paronetto F, Rodriguez-Orengo JF, et al. Slower<br />
fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral<br />
therapy. J Hepatol. 2006 Jan;44(1):47-55.<br />
259. Han<strong>le</strong>y JA, BJ M. A method of comparing the areas under receiver operating characteristic curves derived<br />
from the same cases. Radiology. 1983;148:839-43.<br />
260. Sloand E. Hematologic complications of HIV infection. AIDS Rev. 2005 Oct-Dec;7(4):187-96.<br />
261. Marks KM, Clarke RM, Bussel JB, Talal AH, G<strong>le</strong>sby MJ. Risk Factors for Thrombocytopenia in HIV-<br />
Infected Persons in the Era of Potent Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2009 Sep 3.<br />
187
Change language